Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial
- 31 May 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (5), 814-820
- https://doi.org/10.1016/0959-8049(95)00619-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Factors associated with bacteraemia in febrile, granulocytopenic cancer patientsEuropean Journal Of Cancer, 1994
- Editorial Response: Evolving Risk Factors for Invasive Fungal Infections--All Neutropenic Patients Are Not the SameClinical Infectious Diseases, 1994
- Risk Factors for Fungal Infection in Patients with Malignant Hematologic Disorders: Implications for Empirical Therapy and ProphylaxisClinical Infectious Diseases, 1994
- Efficacy of fluconazole in the treatment of systemic fungal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with FluconazoleNew England Journal of Medicine, 1991
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Empiric antifungal therapy in febrile granulocytopenic patientsAmerican Journal Of Medicine, 1989
- Fungal infections complicating acute leukemiaJournal of Chronic Diseases, 1966